Browsing Tag
CRISPR Therapeutics
6 posts
Gene Editing: Unveiling a Potential $10 Trillion Opportunity
In the realm of healthcare innovation, few advancements hold as much promise and intrigue as gene editing. With…
CRISPR Therapeutics: A Year of Milestones and Momentum
CRISPR Therapeutics (CRSP), a pioneer in gene-editing technology, recently announced its fourth-quarter earnings results, showcasing remarkable performance that…
Unlocking the Potential: Cathie Wood’s Top Pick for 2024 – CRISPR Therapeutics
In the ever-evolving world of biotechnology, one name has risen to the top of the list for innovation…
Bluebird’s Gene Therapy for Sickle Cell Disease Faces FDA Hurdles
Bluebird (BLUE), a pioneering company in the field of gene therapy, has recently applied to the FDA for…
The Tech Trends of 2023 and a Glimpse into 2024: A Year of Innovation and Transformation
As we stand on the precipice of a new year, it’s only natural to look back and reflect…
Unlocking the Potential of CRISPR: Samarth Kulkarni’s Insights on the First FDA Approved Treatment for Sickle Cell Disease
In a groundbreaking interview on CNBC, Samarth Kulkarni, the CEO of CRISPR Therapeutics, shared the remarkable journey of…
